Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BSND pseudogene 4 (BSNDP4) is classified as a pseudogene, which means it is a DNA sequence similar to a functional gene (in this case, the BSND gene encoding barttin) but is generally considered non-functional and does not produce a protein product[8][6]. There are no known biological functions, disease associations, or drug interactions attributed to BSNDP4. The primary relevance of this sequence is its similarity to the functional BSND gene involved in chloride channel activity and associated disease (Bartter syndrome); however, BSNDP4 itself does not encode any known protein or serve as a therapeutic target[8][6]. Additional details: - This pseudogene is cataloged with gene identifiers such as HGNC:51539, NCBI Gene:106481726, and Ensembl:ENSG00000229627[8][6]. - No evidence exists in current sources that BSNDP4 is functional, is associated with disease, or interacts with drugs[8][6]. - By convention and based on database records, "BSND pseudogene 4" refers specifically to the pseudogene, not the functional BSND gene/protein. Note: This entry should not be confused with the functional BSND (“Barttin CLCNK-type accessory subunit beta”) gene, which is critical for chloride channel regulation and associated with Bartter syndrome and sensorineural deafness[1][7][3][5]. BSNDP4 is a non-functional genomic segment with no direct role as a therapeutic or diagnostic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Barttin CLCNK-type chloride channel accessory beta subunit pseudogene 4 (BSNDP4).